Disease ID | Disease name | Source of annotation with PRKCD | OMIM link | Number of associated genes | genes |
---|---|---|---|---|---|
615559 | AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III | ClinVar, OMIM | link to OMIM | 1 | PRKCD |
Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
GnRH signaling pathway | hsa04912 | 6.18 |
Type II diabetes mellitus | hsa04930 | 7.12 |
Tight junction | hsa04530 | 5.53 |
Neurotrophin signaling pathway | hsa04722 | 5.78 |
Fc epsilon RI signaling pathway | hsa04664 | 6.6 |
Fc gamma R-mediated phagocytosis | hsa04666 | 6.21 |
Estrogen signaling pathway | hsa04915 | 6.11 |
Inflammatory mediator regulation of TRP channels | hsa04750 | 6.07 |
Chemokine signaling pathway | hsa04062 | 5.19 |
Vascular smooth muscle contraction | hsa04270 | 5.74 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 7.37 |
PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 7.85 |
DAG and IP3 signaling | R-HSA-1489509 | 7.98 |
Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 7.52 |
Role of phospholipids in phagocytosis | R-HSA-2029485 | 5.47 |
Ca-dependent events | R-HSA-111996 | 8.18 |
Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 7.46 |
G alpha (z) signalling events | R-HSA-418597 | 7.46 |
Immune System | R-HSA-168256 | 2.37 |
Apoptotic execution phase | R-HSA-75153 | 7.28 |
Programmed Cell Death | R-HSA-5357801 | 5.65 |
Downstream signal transduction | R-HSA-186763 | 4.65 |
Effects of PIP2 hydrolysis | R-HSA-114508 | 8.34 |
Calmodulin induced events | R-HSA-111933 | 8.28 |
Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.71 |
CaM pathway | R-HSA-111997 | 8.28 |
Signalling by NGF | R-HSA-166520 | 4.23 |
Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.73 |
Gene Expression | R-HSA-74160 | 2.72 |
Platelet activation, signaling and aggregation | R-HSA-76002 | 5.15 |
Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.26 |
Signaling by EGFR | R-HSA-177929 | 4.59 |
Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.43 |
Interferon gamma signaling | R-HSA-877300 | 5.67 |
Interferon Signaling | R-HSA-913531 | 4.95 |
Signaling by GPCR | R-HSA-372790 | 2.68 |
Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.71 |
Signaling by FGFR4 | R-HSA-5654743 | 4.69 |
Signaling by FGFR3 | R-HSA-5654741 | 4.69 |
C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.06 |
VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.7 |
Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.07 |
Signaling by FGFR | R-HSA-190236 | 4.67 |
GPCR downstream signaling | R-HSA-388396 | 3.07 |
Signaling by ERBB2 | R-HSA-1227986 | 4.66 |
Innate Immune System | R-HSA-168249 | 3.17 |
Signaling by PDGF | R-HSA-186797 | 4.53 |
CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.38 |
DAP12 signaling | R-HSA-2424491 | 4.64 |
Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.71 |
Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.56 |
NGF signalling via TRKA from the plasma membrane | R-HSA-187037 | 4.51 |
PLC-gamma1 signalling | R-HSA-167021 | 7.89 |
Cytokine Signaling in Immune system | R-HSA-1280215 | 3.74 |
EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.89 |
PLC beta mediated events | R-HSA-112043 | 7.52 |
G-protein mediated events | R-HSA-112040 | 7.49 |
Signaling by FGFR2 | R-HSA-5654738 | 4.68 |
Signaling by FGFR1 | R-HSA-5654736 | 4.69 |
Opioid Signalling | R-HSA-111885 | 6.64 |
G alpha (q) signalling events | R-HSA-416476 | 5.42 |
Signaling by VEGF | R-HSA-194138 | 4.66 |
DAP12 interactions | R-HSA-2172127 | 4.56 |
Apoptosis | R-HSA-109581 | 5.68 |
Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.71 |
HuR stabilizes mRNA | R-HSA-450520 | 9.98 |
VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.07 |
Hemostasis | R-HSA-109582 | 3.98 |
Signal Transduction | R-HSA-162582 | 1.78 |
GO term | GO ID | GO IC |
---|---|---|
purine ribonucleoside triphosphate binding | GO:0035639 | 2.22 |
enzyme binding | GO:0019899 | 2.27 |
calcium-independent protein kinase C activity | GO:0004699 | 8.64 |
binding | GO:0005488 | 0.18 |
molecular function regulator | GO:0098772 | 2.51 |
protein kinase C activity | GO:0004697 | 6.97 |
heterocyclic compound binding | GO:1901363 | 1.06 |
nucleoside phosphate binding | GO:1901265 | 1.96 |
nucleoside binding | GO:0001882 | 2.21 |
cation binding | GO:0043169 | 1.4 |
insulin receptor substrate binding | GO:0043560 | 7.25 |
ion binding | GO:0043167 | 1.36 |
protein serine/threonine kinase activity | GO:0004674 | 3.64 |
transferase activity | GO:0016740 | 1.95 |
non-membrane spanning protein tyrosine kinase activity | GO:0004715 | 5.91 |
purine nucleoside binding | GO:0001883 | 2.22 |
protein kinase activity | GO:0004672 | 3.27 |
purine nucleotide binding | GO:0017076 | 2.19 |
metal ion binding | GO:0046872 | 1.41 |
ATP binding | GO:0005524 | 2.43 |
protein tyrosine kinase activity | GO:0004713 | 4.54 |
kinase activity | GO:0016301 | 2.93 |
nucleotide binding | GO:0000166 | 1.96 |
enzyme regulator activity | GO:0030234 | 2.85 |
ribonucleoside binding | GO:0032549 | 2.22 |
protein kinase binding | GO:0019901 | 3.44 |
kinase binding | GO:0019900 | 3.32 |
small molecule binding | GO:0036094 | 1.89 |
adenyl nucleotide binding | GO:0030554 | 2.4 |
carbohydrate derivative binding | GO:0097367 | 2.03 |
organic cyclic compound binding | GO:0097159 | 1.05 |
catalytic activity | GO:0003824 | 1.05 |
phosphotransferase activity, alcohol group as acceptor | GO:0016773 | 3.08 |
adenyl ribonucleotide binding | GO:0032559 | 2.41 |
protein binding | GO:0005515 | 0.46 |
transferase activity, transferring phosphorus-containing groups | GO:0016772 | 2.77 |
purine ribonucleotide binding | GO:0032555 | 2.2 |
purine ribonucleoside binding | GO:0032550 | 2.22 |
ribonucleotide binding | GO:0032553 | 2.19 |
enzyme activator activity | GO:0008047 | 3.56 |